rs116690555
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_004369.4(COL6A3):c.6751C>T(p.Arg2251Trp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000236 in 1,611,808 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004369.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A3 | NM_004369.4 | c.6751C>T | p.Arg2251Trp | missense_variant, splice_region_variant | 26/44 | ENST00000295550.9 | NP_004360.2 | |
COL6A3 | NM_057167.4 | c.6133C>T | p.Arg2045Trp | missense_variant, splice_region_variant | 25/43 | NP_476508.2 | ||
COL6A3 | NM_057166.5 | c.4930C>T | p.Arg1644Trp | missense_variant, splice_region_variant | 23/41 | NP_476507.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A3 | ENST00000295550.9 | c.6751C>T | p.Arg2251Trp | missense_variant, splice_region_variant | 26/44 | 1 | NM_004369.4 | ENSP00000295550.4 | ||
COL6A3 | ENST00000472056.5 | c.4930C>T | p.Arg1644Trp | missense_variant, splice_region_variant | 23/41 | 1 | ENSP00000418285.1 | |||
COL6A3 | ENST00000353578.9 | c.6133C>T | p.Arg2045Trp | missense_variant, splice_region_variant | 25/43 | 5 | ENSP00000315873.4 | |||
COL6A3 | ENST00000491769.1 | n.1005C>T | splice_region_variant, non_coding_transcript_exon_variant | 3/20 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00111 AC: 169AN: 152156Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000312 AC: 77AN: 246866Hom.: 0 AF XY: 0.000263 AC XY: 35AN XY: 133190
GnomAD4 exome AF: 0.000145 AC: 212AN: 1459534Hom.: 1 Cov.: 32 AF XY: 0.000132 AC XY: 96AN XY: 725638
GnomAD4 genome AF: 0.00111 AC: 169AN: 152274Hom.: 1 Cov.: 33 AF XY: 0.00107 AC XY: 80AN XY: 74456
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 06, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 05, 2023 | BS1, PP3 - |
Likely benign, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 20, 2023 | - - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 15, 2016 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2021 | The c.6751C>T (p.R2251W) alteration is located in exon 26 (coding exon 25) of the COL6A3 gene. This alteration results from a C to T substitution at nucleotide position 6751, causing the arginine (R) at amino acid position 2251 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Collagen 6-related myopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Bethlem myopathy 1A Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at